Nuvation Bio Inc. (NUVB) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Nuvation Bio Inc. (NUVB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.66B, listed on NYSE, employing roughly 273 people, carrying a beta of 1.52 to the broader market. Nuvation Bio Inc. Led by David T. Hung, public since 2020-08-26.
Snapshot as of May 15, 2026.
- Spot Price
- $4.34
- ATM IV
- 147.8%
- IV Skew 25Δ
- -0.169
- IV Rank
- 46.8%
- IV Percentile
- 94.8%
- Term Structure Slope
- 0.319
As of May 15, 2026, Nuvation Bio Inc. (NUVB) at-the-money implied volatility is 147.8%. IV rank is 46.8% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 94.8%. The 25-delta skew is -0.169: puts carry meaningful premium over calls, a classic equity downside-protection skew. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
NUVB Strategy Selection at Current Volatility Levels
For Nuvation Bio Inc. options at 147.8% ATM IV, mid-range IV rank (46.8%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. The 25-delta skew is meaningfully put-skewed, so put-credit spreads capture more premium for the same width than call-credit spreads. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked NUVB volatility skew questions
- What is the current NUVB ATM implied volatility?
- As of May 15, 2026, Nuvation Bio Inc. (NUVB) at-the-money implied volatility is 147.8%. IV rank is 46.8% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is NUVB IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does NUVB volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Nuvation Bio Inc. carries the typical equity downside-protection skew: 25-delta puts price meaningfully richer than 25-delta calls. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.